Grand Pharmaceutical Group Limited (0512.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 27.49B |
| Enterprise Value | 31.05B |
| P/E Ratio | 14.98 |
| PEG Ratio | -0.33 |
| Price/Sales Ratio | 1.34 |
| Price/Book Ratio | 0.97 |
| Enterprise/Revenue | 1.69 |
| Enterprise/EBITDA | 9.13 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.09 |
| Operating Margin | 0.12 |
AD
Management Effectiveness
| Return On Assets | 0.04 |
| Return On Equity | 0.07 |
Income Statement
| Revenue | 12.28B |
| Revenue/Share | 3.59 |
| Gross Profit | 6.78B |
| EBITDA | 2.31B |
| Net Income | 1.24B |
| Diluted EPS | 0.35 |
Balance Sheet
| Total Cash | 1.27B |
| Total Cash/Share | 0.36 |
| Total Debt | 5.05B |
| Total Debt/Equity | 0.29 |
| Current Ratio | 1.34 |
| Book Value Per Share | 4.96 |
Price History
| 52-Week Change | -43.2 |
| 52-Week High | 8.97 |
| 52-Week Low | 4.53 |
| Moving Average 50 Days | 5.09 |
| Moving Average 200 Days | 6.24 |
Statistics
| Average Volume | 5.34M |
| Shares Outstanding | 3.5B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.17 |
| Trailing Annual Dividend Yield | 3.52 |
| Payout Ratio | 0.53 |
| Last Split Factor | 519:500 |
| Last Split Date | December 06, 2010 |
AD
